Why the study?
Do different thrombolytic agents (reteplase, streptokinase, alteplase) differentially affect early platelet aggregation and activation in patients with acute myocardial infarction?
Population
126 patients with acute myocardial infarction enrolled in a single center from the RAPID-1, RAPID-2, INJECT…
Comparison
Reteplase or streptokinase vs Alteplase
Design
Cohort
Follow-up
2 hours
Authors
Loading...
May inform thrombolytic selection in AMI; leaves open effects on reperfusion or outcomes.
Do different thrombolytic agents (reteplase, streptokinase, alteplase) differentially affect early platelet aggregation and activation in patients with acute myocardial infarction?
Reteplase and streptokinase induce a more pronounced early decrease in platelet aggregation compared to accelerated alteplase during thrombolytic therapy for acute myocardial infarction.
Moser et al. (1999) studied this question.